A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Isis Tande da et al. Is plasma alpha-tocopherol associated with electronegative LDL in obese adolescents?. Journal of Nutritional Science and Vitaminology, v. 59, n. 2, p. 100-107, 2013Tradução . . Acesso em: 14 out. 2024.
APA
Silva, I. T. da, Mello, A. P. de Q., Sanches, L. B., Abdalla, D. S. P., & Damasceno, N. R. T. (2013). Is plasma alpha-tocopherol associated with electronegative LDL in obese adolescents? Journal of Nutritional Science and Vitaminology, 59( 2), 100-107.
NLM
Silva IT da, Mello AP de Q, Sanches LB, Abdalla DSP, Damasceno NRT. Is plasma alpha-tocopherol associated with electronegative LDL in obese adolescents? Journal of Nutritional Science and Vitaminology. 2013 ; 59( 2): 100-107.[citado 2024 out. 14 ]
Vancouver
Silva IT da, Mello AP de Q, Sanches LB, Abdalla DSP, Damasceno NRT. Is plasma alpha-tocopherol associated with electronegative LDL in obese adolescents? Journal of Nutritional Science and Vitaminology. 2013 ; 59( 2): 100-107.[citado 2024 out. 14 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELLO, Ana Paula Queiroz et al. Electronegative low-density lipoprotein: origin and impact on health and disease. Atherosclerosis, v. 215, n. 2, p. 257-265, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2010.12.028. Acesso em: 14 out. 2024.
APA
Mello, A. P. Q., Silva, I. T. da, Abdalla, D. S. P., & Damasceno, N. R. T. (2011). Electronegative low-density lipoprotein: origin and impact on health and disease. Atherosclerosis, 215( 2), 257-265. doi:10.1016/j.atherosclerosis.2010.12.028
NLM
Mello APQ, Silva IT da, Abdalla DSP, Damasceno NRT. Electronegative low-density lipoprotein: origin and impact on health and disease [Internet]. Atherosclerosis. 2011 ; 215( 2): 257-265.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2010.12.028
Vancouver
Mello APQ, Silva IT da, Abdalla DSP, Damasceno NRT. Electronegative low-density lipoprotein: origin and impact on health and disease [Internet]. Atherosclerosis. 2011 ; 215( 2): 257-265.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2010.12.028
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELLO, Ana Paula de Queiroz et al. Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk. Lipids, v. 45, n. 7, p. 619-625, 2010Tradução . . Disponível em: https://doi.org/10.1007/s11745-010-3439-7. Acesso em: 14 out. 2024.
APA
Mello, A. P. de Q., Silva, I. T. da, Oliveira, A. S., Nunes, V. S., Abdalla, D. S. P., Gidlund, M. A., & Damasceno, N. R. T. (2010). Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk. Lipids, 45( 7), 619-625. doi:10.1007/s11745-010-3439-7
NLM
Mello AP de Q, Silva IT da, Oliveira AS, Nunes VS, Abdalla DSP, Gidlund MA, Damasceno NRT. Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk [Internet]. Lipids. 2010 ; 45( 7): 619-625.[citado 2024 out. 14 ] Available from: https://doi.org/10.1007/s11745-010-3439-7
Vancouver
Mello AP de Q, Silva IT da, Oliveira AS, Nunes VS, Abdalla DSP, Gidlund MA, Damasceno NRT. Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk [Internet]. Lipids. 2010 ; 45( 7): 619-625.[citado 2024 out. 14 ] Available from: https://doi.org/10.1007/s11745-010-3439-7
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELLO, Ana Paula Queiroz et al. Electronegative low density lipoprotein (LDL-) is inversely associated to DHL-cholesterol. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 out. 2024. , 2007
APA
Mello, A. P. Q., Oliveira, A. S. de, Abdalla, D. S. P., Maranhão, R. C., Santos Filho, R. D. dos, & Damasceno, N. R. T. (2007). Electronegative low density lipoprotein (LDL-) is inversely associated to DHL-cholesterol. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Mello APQ, Oliveira AS de, Abdalla DSP, Maranhão RC, Santos Filho RD dos, Damasceno NRT. Electronegative low density lipoprotein (LDL-) is inversely associated to DHL-cholesterol. Atherosclerosis Supplements. 2007 ; 8( 3): 21 res.L018.[citado 2024 out. 14 ]
Vancouver
Mello APQ, Oliveira AS de, Abdalla DSP, Maranhão RC, Santos Filho RD dos, Damasceno NRT. Electronegative low density lipoprotein (LDL-) is inversely associated to DHL-cholesterol. Atherosclerosis Supplements. 2007 ; 8( 3): 21 res.L018.[citado 2024 out. 14 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELLO, Ana Paula de Queiroz et al. Modification of profile LDL- and its auto-antibodies in subjects with different levels of risk cardiovascular and physical activity. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 out. 2024. , 2007
APA
Mello, A. P. de Q., Lima, P. A., Abdalla, D. S. P., Maranhão, R. C., Gidlund, M. A., & Damasceno, N. R. T. (2007). Modification of profile LDL- and its auto-antibodies in subjects with different levels of risk cardiovascular and physical activity. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Mello AP de Q, Lima PA, Abdalla DSP, Maranhão RC, Gidlund MA, Damasceno NRT. Modification of profile LDL- and its auto-antibodies in subjects with different levels of risk cardiovascular and physical activity. Atherosclerosis Supplements. 2007 ; 8( 3): 24 res.L030.[citado 2024 out. 14 ]
Vancouver
Mello AP de Q, Lima PA, Abdalla DSP, Maranhão RC, Gidlund MA, Damasceno NRT. Modification of profile LDL- and its auto-antibodies in subjects with different levels of risk cardiovascular and physical activity. Atherosclerosis Supplements. 2007 ; 8( 3): 24 res.L030.[citado 2024 out. 14 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAMASCENO, Nágila Raquel Teixeira et al. Soy isoflavones reduce electronegative low-density lipoprotein (LDL-) and anti-LDL- autoantibodies in experimental atherosclerosis. European Journal of Nutrition, v. 46, n. 3, p. 125-132, 2007Tradução . . Disponível em: https://doi.org/10.1007/s00394-006-0640-9. Acesso em: 14 out. 2024.
APA
Damasceno, N. R. T., Apolinário, E., Flauzino, F. D., Fernandes, I., & Abdalla, D. S. P. (2007). Soy isoflavones reduce electronegative low-density lipoprotein (LDL-) and anti-LDL- autoantibodies in experimental atherosclerosis. European Journal of Nutrition, 46( 3), 125-132. doi:10.1007/s00394-006-0640-9
NLM
Damasceno NRT, Apolinário E, Flauzino FD, Fernandes I, Abdalla DSP. Soy isoflavones reduce electronegative low-density lipoprotein (LDL-) and anti-LDL- autoantibodies in experimental atherosclerosis [Internet]. European Journal of Nutrition. 2007 ; 46( 3): 125-132.[citado 2024 out. 14 ] Available from: https://doi.org/10.1007/s00394-006-0640-9
Vancouver
Damasceno NRT, Apolinário E, Flauzino FD, Fernandes I, Abdalla DSP. Soy isoflavones reduce electronegative low-density lipoprotein (LDL-) and anti-LDL- autoantibodies in experimental atherosclerosis [Internet]. European Journal of Nutrition. 2007 ; 46( 3): 125-132.[citado 2024 out. 14 ] Available from: https://doi.org/10.1007/s00394-006-0640-9
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Isabela Rosier Olimpio et al. Effects of soy germ isoflavones and hormone therapy on nitric oxide derivatives, low-density lipoprotein oxidation, and vascular reactivity in hypercholesterolemic postmenopausal women. Menopause - The Journal of the North American Menopause Society, v. 13, n. 6, p. 942-950, 2006Tradução . . Disponível em: https://doi.org/10.1097/01.gme.0000248703.22581.8a. Acesso em: 14 out. 2024.
APA
Pereira, I. R. O., Faludi, A. A., Aldrighi, J. M., Bertolami, M. C., Saleh, M. H., Silva, R. A., et al. (2006). Effects of soy germ isoflavones and hormone therapy on nitric oxide derivatives, low-density lipoprotein oxidation, and vascular reactivity in hypercholesterolemic postmenopausal women. Menopause - The Journal of the North American Menopause Society, 13( 6), 942-950. doi:10.1097/01.gme.0000248703.22581.8a
NLM
Pereira IRO, Faludi AA, Aldrighi JM, Bertolami MC, Saleh MH, Silva RA, Nakamura Y, Campos MF, Novaes N, Abdalla DSP. Effects of soy germ isoflavones and hormone therapy on nitric oxide derivatives, low-density lipoprotein oxidation, and vascular reactivity in hypercholesterolemic postmenopausal women [Internet]. Menopause - The Journal of the North American Menopause Society. 2006 ; 13( 6): 942-950.[citado 2024 out. 14 ] Available from: https://doi.org/10.1097/01.gme.0000248703.22581.8a
Vancouver
Pereira IRO, Faludi AA, Aldrighi JM, Bertolami MC, Saleh MH, Silva RA, Nakamura Y, Campos MF, Novaes N, Abdalla DSP. Effects of soy germ isoflavones and hormone therapy on nitric oxide derivatives, low-density lipoprotein oxidation, and vascular reactivity in hypercholesterolemic postmenopausal women [Internet]. Menopause - The Journal of the North American Menopause Society. 2006 ; 13( 6): 942-950.[citado 2024 out. 14 ] Available from: https://doi.org/10.1097/01.gme.0000248703.22581.8a
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIQUEIRA, Antonela F. A. e ABDALLA, Dulcinéia Saes Parra e FERREIRA, Sandra Roberta Gouvea. LDL: da síndrome metabólica à instabilização da placa aterosclerótica. Arquivos Brasileiros de Endocrinologia e Metabologia, v. 50, n. 2, p. 334-343, 2006Tradução . . Disponível em: https://doi.org/10.1590/s0004-27302006000200020. Acesso em: 14 out. 2024.
APA
Siqueira, A. F. A., Abdalla, D. S. P., & Ferreira, S. R. G. (2006). LDL: da síndrome metabólica à instabilização da placa aterosclerótica. Arquivos Brasileiros de Endocrinologia e Metabologia, 50( 2), 334-343. doi:10.1590/s0004-27302006000200020
NLM
Siqueira AFA, Abdalla DSP, Ferreira SRG. LDL: da síndrome metabólica à instabilização da placa aterosclerótica [Internet]. Arquivos Brasileiros de Endocrinologia e Metabologia. 2006 ; 50( 2): 334-343.[citado 2024 out. 14 ] Available from: https://doi.org/10.1590/s0004-27302006000200020
Vancouver
Siqueira AFA, Abdalla DSP, Ferreira SRG. LDL: da síndrome metabólica à instabilização da placa aterosclerótica [Internet]. Arquivos Brasileiros de Endocrinologia e Metabologia. 2006 ; 50( 2): 334-343.[citado 2024 out. 14 ] Available from: https://doi.org/10.1590/s0004-27302006000200020
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAMASCENO, Nágila Raquel Teixeira et al. Detection of electronegative low density lipoprotein (LDL-) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays. Clinical Biochemistry, v. 39, n. 1, p. 28-38, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.clinbiochem.2005.09.014. Acesso em: 14 out. 2024.
APA
Damasceno, N. R. T., Sevanian, A., Apolinário, E., Oliveira, J. M. A. de, Fernandes, I., & Abdalla, D. S. P. (2006). Detection of electronegative low density lipoprotein (LDL-) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays. Clinical Biochemistry, 39( 1), 28-38. doi:10.1016/j.clinbiochem.2005.09.014
NLM
Damasceno NRT, Sevanian A, Apolinário E, Oliveira JMA de, Fernandes I, Abdalla DSP. Detection of electronegative low density lipoprotein (LDL-) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays [Internet]. Clinical Biochemistry. 2006 ; 39( 1): 28-38.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.clinbiochem.2005.09.014
Vancouver
Damasceno NRT, Sevanian A, Apolinário E, Oliveira JMA de, Fernandes I, Abdalla DSP. Detection of electronegative low density lipoprotein (LDL-) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays [Internet]. Clinical Biochemistry. 2006 ; 39( 1): 28-38.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.clinbiochem.2005.09.014